SCHEMBL84112

SCHEMBL84112

NCc1cccc2c1C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 10/20 0.59
MAPT P10636 3/20 0.59
HPGD P15428 2/20 0.59
MEN1 O00255 2/20 0.59
HTT P42858 2/20 0.59
KMT2A Q03164 2/20 0.59
CYP2C19 P33261 1/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.59
SMAD3 P84022 1/20 0.59
PRMT1 Q99873 1/20 0.59
ACE2 Q9BYF1 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
ALDH1A1 P00352 2/20 0.56
ALOX12 P18054 2/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
BRCA1 P38398 1/20 0.56
HSD17B10 Q99714 1/20 0.56
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7640824 0.99 FTO (0.57) FTOMAPTHPGDMEN1HTT
SCHEMBL7647553 0.90 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL4743773 0.89 FTO (0.60) FTOMAPTHPGDMEN1HTT
SCHEMBL2314510 0.89 FTO (0.60) FTOMAPTHPGDMEN1HTT
SCHEMBL336896 0.88 FTO (0.59) FTOMAPTHPGDMEN1HTT
SCHEMBL2184643 0.88 FTO (0.59) FTOMAPTHPGDMEN1HTT
SCHEMBL1115891 0.85 HPGD (0.57) FTOMAPTHPGDMEN1HTT
SCHEMBL22110384 0.85 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL4825622 0.85 FTO (0.56) FTOMAPTHPGDMEN1HTT
SCHEMBL4786947 0.84 FTO (0.50) FTOMAPTHPGDMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110261607-A For detecting the fluorescence polarization immunoassay kit and method of avian leukosis poison 北京市动物疫病预防控制中心 2019-09-20 CN claimed
CN-105136755-A Fluorescence polarization immunoassay method for detection of erythromycin UNIV CHINA AGRICULTURAL 2015-12-09 CN claimed
JP-4711509-B2 2011-06-29 JP claimed
US-20080206788-A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids ADAMCZYK MACIEJ 2008-08-28 US claimed
CN-101048422-A Benzonaphthaceneglycoside derivative and use thereof FUJIFILM CORP (JP) 2007-10-03 CN claimed
EP-0889324-B1 Process for the determination of potassium ions NOVARTIS AG (CH) 2006-09-13 EP claimed
EP-1121599-B1 DETECTION AND QUANTIFICATION OF VANCOMYCIN IN BIOLOGICAL FLUIDS ABBOTT LAB (US) 2004-12-15 EP claimed
US-20040209318-A1 Reagents and methods for the detection and quantification of vancomycin in bilogical fluids ADAMCZYK MACIEJ (US) 2004-10-21 US claimed
US-6797479-B2 IMMUNOASSAY REAGENTS, METHODS AND TEST KITS; ANTIBODY REAGENT PRODUCED WITH IMMUNOGEN-CONJUGATED VANCOMYCIN, A LABELED VANCOMYCIN REAGENT WHICH IS CAPABLE OR DISPLACING THE BINDING OF THE ANTIBODY TO VANCOMYCIN, AND STABLE CALIBRATOR ABBOTT LABORATORIES 2004-09-28 US claimed
JP-2002528704-A 2002-09-03 JP claimed
US-5319105-A Fluorescein derivatives used as storage-stable aqueous solutions for immunoassay, e.g. of monoethylglycinexylidide (MEGX) in blood, a metabolite of lidocaine and indicator of liver function ABBOTT LABORATORIES (US) 1994-06-07 US claimed
WO-1993020094-A1 HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR QUINOLINE ABBOTT LABORATORIES (US) 1993-10-14 WO claimed
WO-1993020442-A1 REAGENTS AND METHODS FOR THE DETECTION AND QUANTIFICATION OF THYROXINE IN FLUID SAMPLES ABBOTT LABORATORIES (US) 1993-10-14 WO claimed
WO-1993020074-A1 HAPTENS, TRACERS, IMMUNOGENS AND ANTIBODIES FOR ACRIDINE-9-CARBOXYLIC ACIDS ABBOTT LABORATORIES (US) 1993-10-14 WO claimed
WO-1993003371-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF IMIPRAMINE OR DESIPRAMINE IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1993-02-18 WO claimed
WO-1993003372-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF TOTAL DOXEPINS IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1993-02-18 WO claimed
WO-1993003370-A1 REAGENTS AND METHODS FOR THE QUANTIFICATION OF AMITRIPTYLINE OR NORTRIPTYLINE IN BIOLOGICAL FLUIDS ABBOTT LABORATORIES (US) 1993-02-18 WO claimed
US-5145790-A Immunoassay, fluorescein derivative ABBOTT LABORATORIES (US) 1992-09-08 US claimed
EP-0373508-A2 Barbiturate assay, tracers, immunogens and antibodies ABBOTT LABORATORIES (US) 1990-06-20 EP claimed
EP-0200960-A1 Total estriol fluorescence polarization immunoassay ABBOTT LABORATORIES (US) 1986-11-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080206788-A1 Reagents and methods for the detection and quantification of vancomycin in biological fluids SERPINA6, CD4, VSIR FTO 3523/4885MAPT 2822/4885HPGD 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.